Carregant...
Measuring health-related quality of life in patients with rare disease
BACKGROUND: There has been a growing emphasis on health-related quality of life (HRQoL) as an important outcome in rare disease drug development, although its assessment may be useful outside the drug development context, including in clinical applications or natural history studies. Central to asse...
Guardat en:
| Publicat a: | J Patient Rep Outcomes |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292508/ https://ncbi.nlm.nih.gov/pubmed/34283357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41687-021-00336-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|